作者
Kirsten Bibbins-Domingo, David C Grossman, Susan J Curry, Karina W Davidson, John W Epling, Francisco AR García, Matthew W Gillman, Alex R Kemper, Alex H Krist, Ann E Kurth, C Seth Landefeld, Michael L LeFevre, Carol M Mangione, William R Phillips, Douglas K Owens, Maureen G Phipps, Michael P Pignone, US Preventive Services Task Force
发表日期
2016/11/15
期刊
Jama
卷号
316
期号
19
页码范围
1997-2007
出版商
American Medical Association
简介
Importance
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults.
Objective
To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in adults.
Evidence Review
The USPSTF reviewed the evidence on the benefits and harms of screening for and treatment of dyslipidemia in adults 21 years and older; the benefits and harms of statin use in reducing CVD events and mortality in adults without a history of CVD events; whether the benefits of statin use vary by subgroup, clinical characteristics, or dosage; and the benefits of various treatment strategies in adults 40 years and older without a history of CVD events.
Conclusions and Recommendations
The USPSTF recommends initiating use of low- to moderate-dose statins in adults aged 40 to 75 years without a history of …
学术搜索中的文章
K Bibbins-Domingo, DC Grossman, SJ Curry… - Jama, 2016
K Bibbins-Domingo, DC Grossman, SJ Curry… - Jama, 2016